Here are the EU hearings about the Pfizer vaccine. Pfizer did not know whether Covid vaccine stopped transmission before rollout. 🚨 BREAKING: In COVID hearing, #Pfizer director admits: #vaccine was never tested on preventing transmission. "Get vaccinated for others" was always a lie. The only purpose of the #COVID passport: forcing people to get vaccinated. …
We already know that about 36% of people who get fully vaccinated by the Pfizer-BioNTech mRNA vaccine will get COVID and have symptoms and 7% will still get serious illness. The 93% prevention of serious illness is great. A full course of the Pfizer-BioNTech vaccine is 64% effective at preventing symptomatic Covid-19, according to an …
By Feb 7, 2021, Israel had administered over 5 million doses of the Pfizer vaccine which covered 60% of its population. Israel has a population 9.3 million people. The US might get to the current Israel vaccination level around May-June. Israel still had a spike in cases in February. Israel was targeting the vaccination of …
Clinical trial data on two COVID-19 vaccines are less protective versus the South Africa coronavirus variant. Novavax reported midstage trial results on Thursday that showed its vaccine was 50% effective overall at preventing COVID-19 among people in South Africa. United Kingdom vaccine results were up to 89.3% effective at preventing COVID-19. Pfizer and Moderna vaccines …
The UK has already approved the Pfizer COVID vaccine. This is ahead of the EU and the USA. Everyone knows the Pfizer COVID vaccine will be approved in each of the jurisdictions. However, the U.S. Food and Drug Administration (FDA) has a meeting planned to discuss Pfizer’s data in depth on 10 December. Dr Scott …
Seven months ago, Nextbigfuture looked at the post pandemic world future as the pandemic was starting. We are now about halfway through the global pandemic. The World Bank’s baseline projection is for a 5.2% global economic contraction. China and several other Asian countries will have positive GDP growth in 2020. The US and many other …
COVID-19 experts were expecting the first vaccines to only be 60% or 70% effective but phase III Pfizer and Biontech results show 90% effectiveness. Test subjects who received two injections of the vaccine three weeks apart had 90% fewer cases of symptomatic Covid-19 than those who received a placebo. Pfizer and Biontech will file for …
Pfizer and BioNTech, announced positive efficacy results from our Phase 3, late-stage study of our potential COVID-19 vaccine. The vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis. The results demonstrate that our mRNA-based vaccine can help …
A letter from Robert Redfield, director of the U.S. Centers for Disease Control and Prevention, is telling states they will soon be receiving permit applications from McKesson Corp to distribute vaccines to places including state and local health departments and hospitals. The CDC is urgently requesting state governor assistance in expediting applications for vaccine distribution …
Various companies will be making card-based COVID-19 tests. These will be simple to use and will be similar to some home pregnancy tests. They will eventually be usable at home but will be usable at schools in the next couple of months. The US government has bought the initial supplies for testing at nursing homes. …
George Church (biotech genius with over two dozen companies several with multi-billion valuation) says he has not stepped outside of his house in five months. He believes the vaccine designed by Estep, his former graduate student at Harvard and one of his protégés, is extremely safe. “I think we are at much bigger risk from …